Attovia Therapeutics, Inc.
ATTO
Positions held
Your positionsATTO isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $744.57M | Enterprise value | $891.99M | Trailing P/E | — | Forward P/E | -6.85 |
| PEG | — | Price / book | -0.51 | Beta | — | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | -48.5% |
| Profit margin | 0.0% | ROE | — | ROA | — | Debt / equity | 0.04 |
| Current ratio | 9.39 | Free cash flow | — | Analyst recommendation | strong_buy | Mean target | $42.20 |
| 52w high | $28.00 | 52w low | $15.48 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|
| Revenue | $0.5M | $0.0M | $0.0M | $0.0M |
| Op margin | -4845.1% | — | — | — |
| Net income | -$20.7M | -$18.7M | -$14.4M | -$15.2M |
| Gross margin | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating income | -$21.8M | -$20.0M | -$16.6M | -$16.1M |
Yearly (6y)
| 2025 | 2024 | |
|---|---|---|
| Revenue | $1.4M | $0.0M |
| Op margin | -4974.7% | — |
| Net income | -$60.6M | -$39.8M |
| Gross margin | — | — |
| Gross profit | — | — |
| Operating income | -$67.2M | -$41.6M |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-22 · Was Moderna Stock's Cancer Vaccine Run Visible In Advance?
2026-09-22 · Attovia Therapeutics (ATTO) Pulls Back As Investors Ask If The Valuation Still Fits
2026-09-03 · Attovia Therapeutics to Participate in Upcoming Investor Conferences
2026-09-02 · Attovia Therapeutics Q2 Net Loss Widens
2026-09-02 · Attovia Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update
2026-08-31 · Attovia Therapeutics Could Serve as Key Player in Immunology, Inflammation, RBC Says
2026-08-31 · Deere upgraded, Lumentum initiated: Wall Street's top analyst calls
2026-08-26 · Moderna Stock Carries A Market Value Its Revenue Does Not Support
2026-08-24 · Moderna Stock Had A Readout Waiting In Plain Sight
2026-08-20 · Moderna's Melanoma Result Landed On A Market Positioned The Other Way
Price (daily)
Full chart · RSI · MACD · patterns